Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis
Author:
Affiliation:
1. University of Toronto; Toronto, Ontario Canada
2. Hospital for Special Surgery; New York New York
Publisher
Wiley
Subject
Rheumatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22063/fullpdf
Reference48 articles.
1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs;Smolen;Ann Rheum Dis,2010
2. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent;Keane;N Engl J Med,2001
3. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA;Nam;Ann Rheum Dis,2010
4. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection;Gomez-Reino;Arthritis Rheum,2007
5. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic;Nolan;JAMA,1999
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023;Reumatología Clínica;2024-05
2. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023;Reumatología Clínica (English Edition);2024-05
3. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;Annals of the Rheumatic Diseases;2022-11-03
4. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;RMD Open;2022-11
5. Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates;Rheumatology International;2021-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3